Kleiter et al. [45] confirmed that Smad7 is overexpressed in peripheral-blood CD4+ T cells of patients with multiple sclerosis during a relapse but not remission; furthermore, this overexpression was strongly associated with T-bet, a T helper 1 (Th1) response transcription factor. This evidence concerns the gene SMAD7 and multiple sclerosis.